ANAFRANIL

Main information

  • Trade name:
  • ANAFRANIL 25 mg coated tablet
  • Dosage:
  • 25 mg
  • Pharmaceutical form:
  • coated tablet
  • Prescription type:
  • Prescription only
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • ANAFRANIL 25 mg coated tablet
    Finland
  • Language:
  • English

Therapeutic information

  • Therapeutic area:
  • Clomipramine
  • Product summary:
  • ; Suitability for use in older adult patients Clomipramini hydrochloridum Avoid using in older persons. Anticholinergic. Sedative. Serotonergic. Risk of QT prolongation. Significant adverse effects include confusion, cognitive disorder, tremor, tachycardia, orthostatic hypotension and serotonin syndrome. Increases risk for falls. Take several interactions into account. Weakens the efficacy of anti-Alzheimer´s drugs.

Status

  • Source:
  • Fimea
  • Authorization status:
  • Marketing authorization granted
  • Authorization number:
  • 5977
  • Authorization date:
  • 11-12-2007
  • Last update:
  • 26-07-2018